Key result
The UCP2-866A allele was associated with SLE susceptibility, and SLE patients had higher malondialdehyde levels than healthy controls.
Why the study?
Increased oxidative stress may lead to accelerated atherosclerosis and cardiovascular disease in SLE, motivating investigation into the association of UCP2 genetic variants and oxidative stress with SLE and atherosclerosis.
Are UCP2 genetic variants and oxidative stress associated with systemic lupus erythematosus and subclinical atherosclerosis?
Case-Control (n=81)
Are UCP2 genetic variants and oxidative stress associated with systemic lupus erythematosus and subclinical atherosclerosis?
The UCP2 -866G/A polymorphism is associated with SLE susceptibility and increased oxidative stress, potentially contributing to accelerated atherosclerosis.
Answers are grounded in this paper and cite their sources.
UCP2 variants may link to oxidative stress in SLE; leaves open any role in atherosclerosis and requires prospective validation before clinical consideration.
BACKGROUND: Increased oxidative stress potentially leads to accelerated atherosclerosis and, consequently, cardiovascular diseases, the main cause of death in systemic lupus erythematous (SLE). To gain insight into these mechanisms, we studied the association of uncoupling protein (UCP) 2 genetic variants, gene involved in the mitochondrial production of reactive oxygen species, and oxidative stress with SLE and the presence of atherosclerosis. METHODS: Genetic analysis of the UCP2 -866G/A and UCP2 Ins/Del polymorphisms was performed in 45 SLE patients and 36 healthy controls by RFLP-PCR. Oxidation status was determined by measuring malondialdehyde (MDA) levels. Presence of subclinical atherosclerosis was investigated by evaluation of intima-media thickness using echo-color-Doppler carotid ultrasound examination. RESULTS: Allelic and genotypic frequencies of the SNPs analysed were evaluated by gene count. Significant association was found between UCP2-866A allele and susceptibility for SLE (P=0.001). Higher levels of MDA were found significantly increased in SLE patients (MDA, 5.05±3.36 µmol/L) compared to normal controls (MDA, 2.79±0.89 µmol/L) (P<0.0001). CONCLUSIONS: Our results suggest that -866G/A UCP2 polymorphism is associated with SLE causing increased ROS production that, in turn, results in increased MDA levels responsible of accelerated atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Gambino et al. (2020) conducted a case-control in Systemic lupus erythematosus (n=81). UCP2 genetic variants (UCP2 -866G/A and UCP2 Ins/Del polymorphisms) vs. Healthy controls was evaluated on Malondialdehyde (MDA) levels (p=<0.0001). The UCP2-866A allele was associated with SLE susceptibility, and SLE patients had higher malondialdehyde levels than healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: